Literature DB >> 31756611

Who is not coming to clinic? A predictive model of excessive missed appointments in persons with multiple sclerosis.

Elizabeth S Gromisch1, Aaron P Turner2, Steven L Leipertz3, John Beauvais4, Jodie K Haselkorn5.   

Abstract

BACKGROUND: Missed appointments can have negative effects on several facets of healthcare, including disruption of services, worse patient health outcomes, and increased costs. The influence of demographic and clinical factors on missed appointments has been studied in a number of chronic conditions, but not yet in multiple sclerosis (MS). Engagement in healthcare services is a particular concern with this population, given the complexity of the condition. Furthermore, excessive missed appointments has emerged as a risk factor for suboptimal adherence to disease modifying therapies (DMTs), prompting further exploration into this issue and whether a tool could be developed to triage possible interventions for persons with MS on DMTs who are missing their appointments. As such, this study aimed to investigate the rate and factors associated with missed appointments among a large national sample of persons with MS and develop a predictive model of excessive missed appointments.
METHODS: Administrative data from 01/01/2013 to 12/31/2015 were extracted from the VA MS Center of Excellence Data Repository. Variables not related to excessive missed appointments, defined as missing more than 20% of scheduled appointments, in bivariate analyses (p > 0.20) were excluded. Remaining baseline co-occurring conditions, demographic, and healthcare utilization variables were entered into a logistic regression model, using a backward elimination criteria of p < 0.05. Calibration and discrimination of the model were assessed. An initial predictive score was generated based on the value of the variable and its β-value from the final model.
RESULTS: The number of missed appointments ranged from 0 to 84 over a two-year period. Over 59% missed at least one appointment, though only 4.28% had excessive missed appointments. Seven variables were retained in the model: adherence to DMTs, age, distance, histories of post-traumatic stress disorder, congestive heart failure, and chronic obstructive pulmonary disease, and emergency visits. Predictive scores ranged from -6.42 to 0.96 (M = -2.61, SD = 1.15). The final model had good discrimination, calibration, and fit.
CONCLUSIONS: By using this model and accompanying score, clinicians could have a good chance of predicting individuals who will miss more than 20% of their appointments and triaging interventions. Published by Elsevier B.V.

Entities:  

Keywords:  Appointment attendance; Multiple sclerosis; No shows; Predictor model; Treatment adherence

Year:  2019        PMID: 31756611     DOI: 10.1016/j.msard.2019.101513

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  The Multiple Sclerosis Centers of Excellence: A Model of Excellence in the VA.

Authors:  Michelle H Cameron; Jodie K Haselkorn; Mitchell T Wallin
Journal:  Fed Pract       Date:  2020-04

Review 2.  Patient No-Show Prediction: A Systematic Literature Review.

Authors:  Danae Carreras-García; David Delgado-Gómez; Fernando Llorente-Fernández; Ana Arribas-Gil
Journal:  Entropy (Basel)       Date:  2020-06-17       Impact factor: 2.524

3.  Characterising the nationwide burden and predictors of unkept outpatient appointments in the National Health Service in England: A cohort study using a machine learning approach.

Authors:  Sion Philpott-Morgan; Dixa B Thakrar; Joshua Symons; Daniel Ray; Hutan Ashrafian; Ara Darzi
Journal:  PLoS Med       Date:  2021-10-12       Impact factor: 11.069

4.  Understanding no-show behaviour for cervical cancer screening appointments among hard-to-reach women in Bogotá, Colombia: A mixed-methods approach.

Authors:  David Barrera Ferro; Steffen Bayer; Laura Bocanegra; Sally Brailsford; Adriana Díaz; Elena Valentina Gutiérrez-Gutiérrez; Honora Smith
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.